Provention Bio, Inc. carries a market capitalization of 2.38B, placing it among publicly traded companies globally.
| Market Cap | 2.38B |
| Enterprise Value | N/A |
Provention Bio, Inc.'s stock has gained approximately 540.51282% over the past 52 weeks. The 50-day moving average sits at 19.10, while the 200-day moving average is 10.15.
| Beta (5Y) | N/A |
| 52-Week Price Change | 540.51282% |
| 50-Day Moving Average | 19.10 |
| 200-Day Moving Average | 10.15 |
| Average Volume (20 Days) | N/A |